Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

A study comparing the efficacy, quality of life and toxicity of cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer in the Indian scenario

Rohan Aurangabadwalla, Rajendra Kumar Jenaw, Nirmal Kumar Jain, Akanksha Jha, Nitin Jain, Nalin Joshi
European Respiratory Journal 2011 38: p2774; DOI:
Rohan Aurangabadwalla
Department of Chest Disease and Tuberculosis, Hospital for Chest Disease and Tuberculosis, Jaipur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajendra Kumar Jenaw
Department of Chest Disease and Tuberculosis, Hospital for Chest Disease and Tuberculosis, Jaipur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nirmal Kumar Jain
Department of Chest Disease and Tuberculosis, Hospital for Chest Disease and Tuberculosis, Jaipur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akanksha Jha
Department of Chest Disease and Tuberculosis, Hospital for Chest Disease and Tuberculosis, Jaipur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nitin Jain
Department of Chest Disease and Tuberculosis, Hospital for Chest Disease and Tuberculosis, Jaipur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nalin Joshi
Department of Chest Disease and Tuberculosis, Hospital for Chest Disease and Tuberculosis, Jaipur, Rajasthan, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 38 no. Suppl 55

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online September 12, 2014.

Copyright & Usage 
© 2011 ERS

Author Information

  1. Rohan Aurangabadwalla,
  2. Rajendra Kumar Jenaw,
  3. Nirmal Kumar Jain,
  4. Akanksha Jha,
  5. Nitin Jain and
  6. Nalin Joshi
  1. Department of Chest Disease and Tuberculosis, Hospital for Chest Disease and Tuberculosis, Jaipur, Rajasthan, India

Article usage

Article usage: January 2014 to May 2022

AbstractFullPdf
Jan 2014100
Feb 2014300
May 20141000
Jul 2014700
Sep 2014100
Nov 2014100
Dec 2014400
Jan 2015300
Feb 2015900
Mar 2015100
Apr 2015600
May 2015500
Jul 2015200
Aug 2015500
Sep 2015400
Nov 2015400
Dec 2015100
Jan 2016100
Feb 2016100
Mar 2016200
May 2016700
Jun 2016600
Jul 2016600
Aug 2016500
Sep 2016700
Oct 2016100
Nov 2016300
Dec 2016800
Jan 2017800
Feb 2017400
Mar 2017900
Apr 2017700
May 2017400
Jun 2017100
Jul 2017600
Aug 2017900
Sep 2017600
Oct 2017800
Nov 2017400
Dec 2017900
Jan 2018500
Feb 20181200
Mar 2018200
Apr 2018300
May 2018300
Jun 2018200
Jul 2018100
Aug 2018600
Sep 2018300
Oct 2018200
Nov 20181100
Dec 2018900
Jan 2019400
Feb 2019400
Mar 2019200
Apr 2019800
May 2019200
Jun 2019300
Jul 2019400
Aug 2019300
Sep 2019500
Nov 2019600
Dec 2019100
Jan 2020500
Feb 2020200
Mar 20201700
Apr 20201000
May 2020100
Jul 2020600
Aug 20201500
Sep 20201300
Oct 2020800
Nov 2020500
Dec 2020700
Jan 2021300
Feb 2021900
Mar 2021300
Apr 2021500
May 2021500
Jun 20211000
Jul 20212200
Aug 20213300
Sep 2021800
Oct 2021800
Nov 20211400
Dec 2021900
Jan 20222100
Feb 2022400
Mar 2022700
Apr 2022300
May 2022400

Altmetrics

Previous
Back to top
Vol 38 Issue Suppl 55 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A study comparing the efficacy, quality of life and toxicity of cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer in the Indian scenario
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A study comparing the efficacy, quality of life and toxicity of cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer in the Indian scenario
Rohan Aurangabadwalla, Rajendra Kumar Jenaw, Nirmal Kumar Jain, Akanksha Jha, Nitin Jain, Nalin Joshi
European Respiratory Journal Sep 2011, 38 (Suppl 55) p2774;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
A study comparing the efficacy, quality of life and toxicity of cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer in the Indian scenario
Rohan Aurangabadwalla, Rajendra Kumar Jenaw, Nirmal Kumar Jain, Akanksha Jha, Nitin Jain, Nalin Joshi
European Respiratory Journal Sep 2011, 38 (Suppl 55) p2774;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Hematological toxicity associated with gemcitabine/cisplatin in elderly non-small cell lung cancer patients
  • Complete regression of eyeball metastasis secondary to non-small-cell lung cancer with intravitreal cisplatin and vinorelbin therapy
  • Survival of lung cancer patients with bone metastases
Show more 286. Palliation and morbidity in lung cancer patients

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society